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INTRODUCTION
Glucagonomas are rare, constituting only about 6%
of all islet cell tumors l’ 2. The incidence of islet cell
tumors associated with pancreatitis is apparently much
lower than that of pancreatic exocrine tumors3-5,
only 13 patients currently being identified in the
literature6-16. Although aware of another patient with
a glucagonoma associated with chronic pancre
atitis 17, we currently find no report of such an associa-
tion in the literature. Because of its rarity and its
possbile implications, the observations of a pancre-
atic glucagonoma association with acute and chronic
pancreatitis with pancreatic lithiasis seem worthy of
presentation.
SUMMARY
A Patient with a glucagonoma associated with cal-
culous pancreatitis is reported. The authors know of
only one other such patient. Because the calculous
pancreatitis developed both upstream and down-
stream from the tumor, it cannot be attributed to
obstruction of the pancreatic duct by the tumor. Con-
tinued critical appraisal is needed to determine
whether the association of the glucagonoma and
pancreatitis is etiologically related or merely coinci-
dental.
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CASE REPORT
A 49 year-old white female business executive was
rehospitalized with a 20 month history of recurrent
attacks of acute pancreatitis. During the last eight
months her abdominal pain had been severe, refrac-
tory and typical of chronic pancreatitis. Detailed ex-
ploration of her personal and familial history, as well
as multiple biochemical and hematological profiles,
including normal serum total protein, albumin, cal-
cium, lipids, and glucose, revealed no suggestion of
any etiological factor. She had no gallstones and had
neither diabetes nor steatorrhea. There was no history
of renal calculi nor hyperpara-thyroidism. Physical
examination revealed a slender, energetic, intelligent
woman with tenderness across the upper abdomen.
Her skin and tongue were normal.
CT scan and plain roentgenograms, showed pancre-
atic calcification, but no tumor in the head of the
pancreas (Fig. 1). ERCP revealed a pancreatic duct
which was dilated throughout its entire course (Fig. 2),
no obstruction of the duct being detected. Longitudi-
nal pancreaticojejunostomy was elected for interrup-
tion of her pancreatic pain.
At laparotomy, February 4, 1992, the pancreatic
duct (1.0-1.3 cm diameter) was incised longitudinally
in the body and head of the gland. The gland was
atrophic, firm, and typical of advanced chronic pan-
creatitis. Numerous intraductal calculi were present in
the head and body. In the uncinate process, an irregu-
larly surfaced, white stone branched into the small
ductal tributaries. All recognizable stones were
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Figure 1 CT scan-stones (solid arrow) and the dilated pancreatic duct are observed.
Figure 2 ERCP shows the dilation of the pancreatic duct through the pancreas (arrow) and the stones in the small ducts of the uncinate
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removed. Meanwhile, it had become apparent that the
incision had transected a 1.0-1.5 cm pancreatic tumor
overlying, but neither invading nor obstructing, the
duct in the neck of the pancreas. Frozen section was
reported as demonstrating a malignant tumor, "prob-
ably acinar cell" in type. Second and third opinions by
pathologists concurred. A radical resection of the head
and body of the pancreas, including skeletonization of
the adjacent vessels, was performed. Histologically,
the pancreas revealed atrophy of the acini with exten-
sive fibrosis. The tumor consisted of small cell clusters
scattered within a dense connective tissue. Most tumor
cells were reactive with anti-glucagon antibody
(Fig. 3) and only a few with anti-insulin, or anti-
somatostatin. No reactivity was seen with anti-pancre-
atic polypeptide. In some areas, tumor cells, unreactive
with any of the above antibodies, formed tubular or
glandular structures (Fig. 4). Despite their apparent
diffuse growth, no vascular nor neural invasion could be
identified.
The patient’s convalescence was uneventful. Over
the ensuing three and a half years, she has remained
entirely well. Her blood glucose levels remain normal,
as do her biochemical and hematological profiles. Her
plasma glucagon level is normal and repeated CT
scans of the abdomen and chest x-rays reveal no
evidence of metastasis.
DISCUSSION
In 1942, Becker et al.
8 reported an association be-
tween a pancreatic tumor and a peculiar dermatitis in
a patient with diabetes, weight loss and anemia, but the
.glucagonoma was not well recognized until 1966 when
McGravan et al.
19 documented the presence of ele-
vated glucagon levels in the blood and tumor tissue of
a patient with an alpha-cell pancreatic neoplasm. To
date, approximately 200 glucagonomas have been re-
ported2’21. Most patients have presented, in varying
degrees, with the "glucagonoma syndrome" (i.e. hypo-
aminoacidemia, anemia, glucose intolerance, migra-
tory necrolytic dermatitis, weight loss, stomatitis,
Figure 3 Cords of tumor cells in a dense connective tis-
sue. Most tumor cells have reacted with anti-glucagon and
a few with anti-insulin or anti-somatostatin but none with
anti-pancreatic polypeptide. ABC method. Bar 100 tm.
Figure 4 Another area of the same tumor in Fig. 3.
Tumor cells forming small cords have reacted with anti-
glucagon, but the cells constituting the glandular struc-
tures within the tumor were unreactive with antibodies
against insulin, glucagon, somatostatin or PP. Note the
dense connective tissue. ABC method. Bar 100 tm.80 CHUANYAN MAO et al.
thromboembolism). Since the development of the
radioimmunoassay and immunohistochemical stain-
ing, an increasing number of glucagonomas have been
diagnosed earlier, apparently preceding the develop-
ment of a "glucagonoma syndrome’’22. Such a syn-
drome was not recognized, even retrospectively, in our
patient. There was no glossitis, skin rash, elevated
blood glucose level nor other sign of endocrine abnor-
mality so that serum hormone levels had not been
determined preoperatively. Immunohistochemical stains
of the tumor demonstrate glucagon containing gran-
ules, indicative of their alpha-cell origin. Glucagono-
mas, as other islet cell neoplasms, may secrete multiple
hormones, either entopic or ectopic, e.g. insulin,
pancreatic polypeptide, somatostatin, ACTH8, or
calcitonin23. In the current tumor, insulin and soma-
tostatin were detected as minor hormone products on
immunohistochemical staining. It has been estima-
ted
24 that 70% of glucagonomas are malignant and
over 50% have metastasized at the time of diagnosis.
So far, we recognize no stigmata of malignancy in our
patient.
Glucagonoma associated with pancreatitis, especi-
ally pancreatolithiasis, must be extremely rare as we
have not found such a report in the literature. Through
personal communication, we are aware of another
patient inwhom a glucagonoma invaded and obstructed
the pancreatic duct, apparently causing chronic pan-
creatitis upstream from the obstruction 17.
Glucagon suppresses secretion of pancreatic juice,
but any mechanism of its possible induction of pan-
creatitis or pancreatic lithiasis is not evident. Mechani-
cal obstruction of the pancreatic duct is usually
considered the etiology of tumor-related pancreatitis,
although parathyroid tumors are well recognized causes
of pancreatitis and pancreatic lithiasis. Our clinical ex-
perience and a review of the literature of pancreatitis
associated with islet cell tumors partially supports the
obstructive mechanism9’1’13. On the other hand, the
duct is not always obstructed. For example, Mitchenere
et al. reported a patient with an islet cell adenoma
associated with acute pancreatitis, no ductal obstruc-
tion being found by pancreatography. Kaufman et al.
11
reported a tumor in the tail of the pancreas, but a
pseudocyst developed in the head. In the current case,
the pancreatic duct was not obstructed by the tumor;
the duct was dilated and filled with calculi both up-
stream and downstream from the tumor.
Allison and associates described the finding
of calcific pancreatitis in an alcoholic patient with a
malignant islet cell tumor which secreted gastrin,
ACTH and apparently human chorionic gonadotro-
phin. Perhaps our patient had chronic idiopathic pan-
creatitis, by chance associated with a glucagonoma,
but a cause and effect relationship remains an intriguing
possibility.
The rarity of acinar cell carcinomas and their cellu-
lar appearance have previously caused them to be
erroneously diagnosed as islet cell tumors-the reverse
of the currrent events.
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